As the multi-year attack on Maine's medical market plays out, again, there is something distinctly unnerving about MSO's like Curaleaf (among others) claiming to support policy reform efforts in some states while, at the same time, targeting caregivers, attempting to ban gifting/undermine equity joint ventures in Connecticut and working to centralize control over first mover advantage in limited license states such as New Jersey.
Maybe I'm just a little bit jaded, but that approach very much makes me concerned about the intentions of some of these companies and their work (by proxy or otherwise) in policy arenas nationwide (not too mention the impact those companies may have on federal legalization).
It was, after all, some of these very same companies who spent years pushing for a police task force in this state designed to target the unregulated market while, at the same time, fighting local equity efforts with an explicit aim of protecting a consolidated market oligopoly.
Original source can be found here
